Thousands of women could benefit from a "revolutionary" new breast cancer treatment which could be delivered in a single dose of radiotherapy during surgery rather than several courses of treatment.
The "intrabeam therapy" has been given the green light by the NHS and the National Institute for Health and Care excellence (Nice) said the treatment option should be considered for people with early stage breast cancer.
Tens of thousands of breast cancer sufferers could soon be receiving an "innovative" type of radiotherapy treatment, it has emerged.
The National Institute for Health and Care excellence (Nice) gave intrabeam radiotherapy the seal of approval for use on the NHS.
The treatment involves administering a single dose of radiotherapy to patients during surgery.
A single dose of radiotherapy could be "more convenient" for patients, Nice said.
Intrabeam radiotherapy will be available to patients in the early stages of breast cancer.
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.